TNBC:

Mohammed Ridha Moamin1, Richard Allen1, Steven Leslie Woods1

  • 1Division of Clinical Medicine, School of Medicine & Population Health, Faculty of Health, Sheffield, United Kingdom.

Frontiers in immunology
|December 13, 2023
PubMed
概括

经过新辅助化疗 (NAC) 后仍然没有疾病的高风险三阴性乳腺癌 (TNBC) 患者表现出周围血管 (PV) 免疫细胞的增加,特别是TIM-3+CD163+TAMs. 这表明了复发风险和潜在的免疫疗法标的新标记.